Citations

Showing 10 of 108083 citations.

Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. III. Epidermal cell-specific cytotoxic T lymphocytes.
Tyler, J D, Steinmuller, David

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 126 | Issue: 5 | Pages: 1759-1763

10.4049/jimmunol.126.5.1759 Get It

Abstract We have previously shown that murine epidermal cells (EC) from 5 H-2 compatible donor strains induce cytotoxic T lymphocytes (CTL) in C3H hosts that preferentially lyse donor EC as opposed to donor lymphoid cells (LC). This preference has been shown to be dependent on a single alloantigen disparity, designated epidermal alloantigen (Epa). In this report we studied the specificity of the CTL to determine whether Epa-antigens are in fact EC specific. Two populations of CTL could be identified by cross-immunization, cold-target inhibition, antigen-driven suicide, and limiting-dilution analyses. A minor CTL population recognizes alloantigens that are expressed by both EC and LC, but this population is necessary only for lysis of LC targets. The major CTL population is specific for Epa-antigens and reacts only with EC targets. At the induction phase of CTL responses, donor LC stimulators can weakly stimulate Epa-specific CTL, indicating LC populations express Epa-antigens in immunogenic form but at very low levels compared with EC. The preferential lysis of EC targets in these strain combinations can be attributed to the major Epa-specific CTL population, whereas lysis of LC targets is due to CTL specific for other alloantigens that are shared by EC and LC. The identification of CTL-activating, EC-specific alloantigens may help to explain the extreme immunogenicity of MHC compatible skin allografts.
Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. II. Genetic basis of the response of C3H mice.
Steinmuller, David, Tyler, J D, David, C S

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 126 | Issue: 5 | Pages: 1754-1758

10.4049/jimmunol.126.5.1754 Get It

Abstract Epidermal cells (EC) of AKR and CBA (H-2k) mouse strains share non-H-2 alloantigens that induce potent cytotoxic T lymphocytes (CTL) in H-2 compatible C3H hosts, and these CTL lyse EC targets in preference to lymphoid cell (LC) targets in H-2-restricted fashion in short-term cell-mediated cytotoxicity (CMC) assays. In contrast, C3H EC are not immunogenic in this regard in AKR and CBA hosts. (C3H × CBA)F1 hybrid hosts are nonresponders to AKR EC, exactly like the CBA parent strain hosts, and their own EC are immunogenic in C3H hosts and susceptible to lysis by the CTL so generated. Hence, CBA mice express a non–H-2 CMC determinant on EC that is absent on C3H EC. Offspring produced by backcrossing (C3H × CBA)F1 hybrids to the antigen-negative C3H parent strain were tested individually for their responsiveness to AKR EC immunogens and for the susceptibility of their own EC to lysis by C3H anti-AKR EC effectors. There was a clear 1: 1 distribution of the backcross offspring into 2 populations in both test systems. Moreover, responsiveness and antigenicity were inversely correlated in individual mice. Thus, the expression of EC alloantigens in the segregating offspring depends on the activity of genes at a single Mendelian locus. These results are most compatible with the hypothesis that a loss mutation occurred early in the history of the C3H strain at a non-H-2 locus that specifies a system of alloantigens expressed preferentially on EC. The finding that CTL generated by AKR EC immunogens in C3H/Heston and C3H/Andervont mice exhibit the same preferential lysis of EC as opposed to LC targets is consistent with this hypothesis because these C3H strains separated over 40 yr ago. Because this locus does not appear to correspond to any known locus, we have provisionally designated it the Epa (epidermal alloantigen) locus.
Genetic control of experimental autoimmune myasthenia gravis in mice. II. Lymphocyte proliferative response to acetylcholine receptor is dependent on Lyt-1+23- cells.
Christadoss, Premkumar, Krco, Christopher J., Lennon, Vanda A. , David, Chella S.

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 126 | Issue: 4 | Pages: 1646-1647

10.4049/jimmunol.126.4.1646 Get It

Abstract The proliferative response of regional lymph node lymphocytes to Torpedo acetylcholine receptor (TAR) is under H-2 linked Ir gene control. In high responder B6 (H-2b) congenic mice, lymphocytes that proliferate in vitro in response to TAR are dependent on T cells of a subpopulation expressing the phenotype associated with helper functions, Lyt-1+23-.
Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. I. H-2 restricted reactions among strains sharing the H-2k haplotype.
Steinmuller, David, Tyler, J D, David, C S

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 126 | Issue: 5 | Pages: 1747-1753

10.4049/jimmunol.126.5.1747 Get It

Abstract Epidermal cells (EC) obtained by trypsinization of tail skin of H-2k haplotype mouse strains AKR, B10.BR, B10.K, CBA, C3H, and RF were used as stimulators and targets of cell-mediated cytotoxicity (CMC) in 3-hour chromium-release assays. Host splenic effector cells were generated by priming mice with an injection of EC and boosting in mixed culture with irradiated donor-strain EC stimulators; then assayed for CMC towards donorstrain EC and lymphoid cell (LC) targets. When C3H is the donor strain and any of the other strains the host, little CMC is registered with EC targets. However, when C3H is the host and any of the other strains the donor, the CMC registered with donor-strain EC targets invariably is greater than that registered with LC targets, even with mitogen-induced lymphoblasts, indicating that C3H mice respond to non-H-2 alloantigens preferentially expressed by EC. The CMC evoked in C3H hosts by EC from any of the other other H-2k strains cross-reacts with EC targets from all of them, indicating extensive sharing of target-cell determinants. However, the CMC is H-2 restricted, and mapping tests with recombinant lines on the C57BL/10 background proved that the restriction depends on antigens mapping in the K region of the H-2 complex. T cell elimination tests indicate that the effector cells in these reactions are cytotoxic T lymphocytes. Moreover, tests conducted with medium supplemented with adult mouse serum instead of fetal calf serum indicate that the reactions are not dependent on xenogeneic serum but represent true examples of H-2-restricted CMC directed towards non-H-2 alloantigens expressed preferentially on EC.
Inhibitors of DNA synthesis produced by herpesvirus-transformed cell lines.
Beneke, J, Pearson, Gary R.

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 124 | Issue: 6 | Pages: 2944-2949

10.4049/jimmunol.124.6.2944 Get It

Abstract Inhibitory factors were detected in the supernatant fluids of two herpesvirus-transformed lymphoid cell lines, one a B cell line established from a cotton-topped marmoset with EBV-induced lymphoma (1605L) and the other a HVS-transformed marmoset T cell line (C-1 Ax). The factors produced by both cell lines inhibited the uptake of 125I-iododeoxyuridine (125I-IUDR) by lymphocytes stimulated by both phytohemagglutinin and pokeweed mitogen. Both factors also suppressed the uptake of 125I-IUDR by cells of lymphoid cell lines of both B and T cell origin, indicating that neither factor was specific for lymphoid subpopulations. Furthermore, the factor produced by the 1605L cell line did not exhibit tissue specificity in the target cells that it affected, since it also suppressed 125I-IUDR uptake by the HEp-2 cell line, which is epithelial. Antibody-dependent cellular cytotoxicity, an assay that has been reported to require effector cells capable of protein synthesis but not DNA synthesis, was not suppressed by either factor, indicating that these inhibitors acted at the level of DNA synthesis. Experiments investigating the kinetics of the inhibition of PHA blastogenesis by the 1605L factor suggested that this inhibitor blocked an early stage in the DNA synthetic cycle, since maximum inhibition was observed only when the factor was present early in the culture period.
A Reexamination of Humoral Tolerance in Chickens Congenitally Infected with an Avian Leukosis Virus
Qualtiere, Louis F., Meyers, Paul A.

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 122 | Issue: 3 | Pages: 825-829

10.4049/jimmunol.122.3.825 Get It

Abstract In a reexamination of congenital infection of chickens with ALV, one of the classical models of immunologic tolerance, we were unable to demonstrate that there was any evidence suggesting humoral immune reactivity to the infecting virus. In ALV-F42 congenitally infected birds that have a persistent viremia and no neutralizing antibody detectable by conventional means, we could find no evidence of host IgG deposits in the kidneys, nor any suggestion of renal pathology or damage. In addition, attempts to precipitate any putative circulating infections virus-antibody complexes by treatment with a highly specific anti-globulin were negative nor were there titer differences in the viremic plasmas of bursectomized birds compared to nonbursectomized birds, indicating that the chickens were not making either a masked neutralizing or a nonneutralizing antibody response to the infecting virus. The evidence presented indicates that congenital infection of chickens with ALV does, at least at the humoral level, result in a state of immunologic tolerance to the infecting agent.
Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera.
Wooley, P H, Luthra, Harvinder S., Huse, A., Stuart, J., David, C S, Lafuse, William P. , Stuart, J M

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 134 | Issue: 4 | Pages: 2366-2374

10.4049/jimmunol.134.4.2366 Get It

Abstract Pretreatment of mice genetically susceptible to type II collagen-induced arthritis (CIA) with monoclonal or polyclonal antisera specific for I region gene products (Ia antigens) suppressed or delayed the onset of CIA, whereas pretreatment with anti-Ia to an irrelevant haplotype was without effect. The humoral response to type II collagen was transiently depressed 14 days after immunization but antibody levels did not differ significantly after 28 days. The peak delayed-type hypersensitivity to type II collagen was unaffected by anti-Ia treatment. Monoclonal antibody of one anti-Ia specificity enhanced both the antibody response and the arthritis incidence in one mouse strain.
Production of Human Immunoglobulin E Antibody In Vitro
Tjio, Anthony H., Hull, William M. , Gleich, Gerald J.

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 122 | Issue: 5 | Pages: 2131-2133

10.4049/jimmunol.122.5.2131 Get It

Abstract The discovery of immunoglobulin E (IgE) (1) has contributed significantly to the understanding of hypersensitivity reactions mediated by reaginic antibody (2) and has led to the development of new diagnostic procedures in the field of allergology (3, 4). Recent studies have demonstrated the production of IgE protein by peripheral blood lymphocytes in vitro and have examined the kinetics and pharmacologic control of IgE biosynthesis (5, 6). The purpose of this communication is to describe our observation of in vitro production of IgE protein and antigen-specific IgE antibodies by peripheral blood mononuclear cells obtained from atopic and nonatopic individuals. A modification of the lymphocyte culture method of Waldmann et al. (7) was used in our studies. Blood, 60 ml, was obtained from 11 patients, eight of whom are atopic (geometric mean serum IgE, 247 ng/ml; range 61 to 1079) and three of whom are nonatopic (geometric mean serum IgE, 96 ng/ml; range 73 to 143).
Non-H-2 Linked Control of Low Versus High Responses of Antigen-Induced Lymph Node Cell Proliferation: Possible Role for Antigen-Presenting Cells
Fathman, C. Garrison, Tomasi, Thomas B., Suzuki, Koji A. O.

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 123 | Issue: 4 | Pages: 1530-1534

10.4049/jimmunol.123.4.1530 Get It

Abstract Quantitative differences in the magnitude of antigen-induced proliferative responses of sensitized lymph node cells between low (C3H/Anf or C3H/Cr) and high (C3H/Hej or CBA/j) responder H-2k mice have been observed 1 to 2 weeks after in vivo sensitization with antigen (OVA, PPD, and GAT). We have shown that antigen presentation is less effective in the sensitized lymph node cell populations from low responder mice compared with those from high responder mice, suggesting that the number and/or functional status of antigen-presenting cells in the regional lymph nodes may be a key factor in determining the magnitude of antigen-induced proliferative responses. These data are consistent with the hypothesis that cell traffic after sensitization plays an important role in determining the immune responsiveness of lymph nodes.
A new lymphocyte surface protein present in normal urine. I. Isolation and physicochemical properties.
Calvanico, N J, Velosa, Jorge A., Anderson, William L. , Tomasi, T. B. , Anderson, W L

Mayo Clinic

The Journal of Immunology | December 31, 2022 | Volume: 124 | Issue: 1 | Pages: 173-177

10.4049/jimmunol.124.1.173 Get It

Abstract A lymphocyte surface glycoprotein designated urinary acidic antigen (UA) has been isolated from normal urine by a combination of preparative isoelectric focusing and ammonium sulfate precipitation. It has an m.w. of 14,000 to 17,500 daltons, and is approximately 60% carbohydrate and 40% amino acid in content. The protein exhibited the following physical properties: S20,omega = 1.24; v = 0.693 ml/g; E1%1 cm, 278 nm = 2.08; and pI-2.5. It appears to be unrelated to beta 2-microglobulin, protein HC, urinary proteose, microglobulin, or any previously described normal urine or human serum protein.